Gossamer Bio, Inc. (GOSS) Q2 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

and thank you for standing by. Welcome to the Gossamer Bio Q2 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 1 on your telephone keypad. And if you require any further assistance, just press star 0. And I would now like to turn the call over to your first speaker, Brian Jurado, Chief Financial Officer. You may begin your conference. Thank you, Operator, and thank you all for joining us this afternoon. I'm joined on today's call by Gossamer Biles Chairman, Co-Founder and Chief Executive Officer, Christine Hadley, Richard Aranda, Gossamer Biles Chief Technical Officer, as well as Laura Carter, Gossamer Biles Chief Scientific Officer. Earlier this afternoon, Gossamer Bio issued a press release announcing its financial results for the second quarter ended June 30, 2021, in addition to providing a corporate update. Please note that certain information discussed on the call today is covered under the safe harbor provision of the private securities litigation reform act. We caution listeners that during this call, Gossamer Management will be making forward-looking statements. Actual results may differ materially from those stated or implied by these forward-looking statements due to the risks and uncertainties associated with the company's business. These forward-looking statements are qualified by the statements contained in Gossamer's news releases and SEC filings, including in the annual report on Form 10-K and subsequent filings. This conference call also contains consensual information that may be accurate for only a limited period of time. Our ability to meet our guidance, especially that related to ...